- Home
- RAPT vs INNV Comparison
RAPT vs INNV Comparison
Compare RAPT & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | INNV |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 485.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RAPT | INNV |
|---|---|---|
| Price | $57.77 | $8.73 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 10 | 1 |
| Target Price | ★ $56.22 | $5.00 |
| AVG Volume (30 Days) | ★ 4.1M | 252.0K |
| Earning Date | 03-05-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $915,371,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | N/A | $9.58 |
| P/E Ratio | ★ N/A | $174.85 |
| Revenue Growth | N/A | ★ 13.48 |
| 52 Week Low | $5.67 | $2.60 |
| 52 Week High | $57.86 | $8.40 |
Technical Indicators
Market Signals| Indicator | RAPT | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 79.64 | 77.86 |
| Support Level | $57.61 | $5.38 |
| Resistance Level | $57.80 | $8.09 |
| Average True Range (ATR) | 0.12 | 0.53 |
| MACD | -0.22 | 0.31 |
| Stochastic Oscillator | 75.00 | 95.47 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.